Annual revenue:
$705.14M-$82.51M(-10.48%)Summary
- As of today (May 8, 2025), IONS annual revenue is $705.14 million, with the most recent change of -$82.51 million (-10.48%) on December 31, 2024.
- During the last 3 years, IONS annual revenue has fallen by -$105.32 million (-12.99%).
- IONS annual revenue is now -37.19% below its all-time high of $1.12 billion, reached on December 31, 2019.
Performance
IONS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$131.61M-$94.96M(-41.91%)Summary
- As of today (May 8, 2025), IONS quarterly revenue is $131.61 million, with the most recent change of -$94.96 million (-41.91%) on March 31, 2025.
- Over the past year, IONS quarterly revenue has increased by +$12.12 million (+10.14%).
- IONS quarterly revenue is now -73.34% below its all-time high of $493.68 million, reached on December 31, 2019.
Performance
IONS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$717.25M+$12.12M(+1.72%)Summary
- As of today (May 8, 2025), IONS TTM revenue is $717.25 million, with the most recent change of +$12.12 million (+1.72%) on March 31, 2025.
- Over the past year, IONS TTM revenue has dropped by -$59.37 million (-7.64%).
- IONS TTM revenue is now -36.11% below its all-time high of $1.12 billion, reached on December 31, 2019.
Performance
IONS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
IONS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.5% | +10.1% | -7.6% |
| 3 y3 years | -13.0% | -7.3% | -14.7% |
| 5 y5 years | -37.2% | -1.3% | -25.2% |
IONS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.0% | +20.1% | -59.4% | +10.1% | -18.1% | +24.5% |
| 5 y | 5-year | -37.2% | +20.1% | -70.1% | +17.9% | -25.2% | +24.5% |
| alltime | all time | -37.2% | >+9999.0% | -73.3% | +6680.6% | -36.1% | >+9999.0% |
Ionis Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $131.61M(-41.9%) | $717.25M(+1.7%) |
| Dec 2024 | $705.14M(-10.5%) | $226.58M(+69.3%) | $705.14M(-12.2%) |
| Sep 2024 | - | $133.81M(-40.6%) | $803.07M(-1.3%) |
| Jun 2024 | - | $225.25M(+88.5%) | $813.46M(+4.7%) |
| Mar 2024 | - | $119.50M(-63.2%) | $776.62M(-1.4%) |
| Dec 2023 | $787.65M(+34.1%) | $324.50M(+125.0%) | $787.65M(+28.1%) |
| Sep 2023 | - | $144.21M(-23.5%) | $615.03M(-2.5%) |
| Jun 2023 | - | $188.41M(+44.3%) | $630.59M(+9.5%) |
| Mar 2023 | - | $130.52M(-14.1%) | $575.97M(-1.9%) |
| Dec 2022 | $587.37M(-27.5%) | $151.89M(-4.9%) | $587.37M(-32.9%) |
| Sep 2022 | - | $159.77M(+19.4%) | $875.48M(+3.1%) |
| Jun 2022 | - | $133.79M(-5.7%) | $848.81M(+1.0%) |
| Mar 2022 | - | $141.92M(-67.7%) | $840.77M(+3.7%) |
| Dec 2021 | $810.46M(+11.1%) | $440.01M(+230.6%) | $810.46M(+22.7%) |
| Sep 2021 | - | $133.09M(+5.8%) | $660.73M(-3.9%) |
| Jun 2021 | - | $125.75M(+12.7%) | $687.72M(-2.8%) |
| Mar 2021 | - | $111.61M(-61.6%) | $707.50M(-3.0%) |
| Dec 2020 | $729.26M(-35.0%) | $290.28M(+81.3%) | $729.26M(-21.8%) |
| Sep 2020 | - | $160.08M(+10.0%) | $932.66M(-0.8%) |
| Jun 2020 | - | $145.54M(+9.1%) | $940.48M(-1.9%) |
| Mar 2020 | - | $133.37M(-73.0%) | $958.75M(-14.6%) |
| Dec 2019 | $1.12B(+87.2%) | $493.68M(+194.0%) | $1.12B(+36.7%) |
| Sep 2019 | - | $167.89M(+2.5%) | $821.03M(+2.8%) |
| Jun 2019 | - | $163.81M(-44.9%) | $798.54M(+6.1%) |
| Mar 2019 | - | $297.21M(+54.7%) | $752.47M(+25.5%) |
| Dec 2018 | $599.67M(+16.6%) | $192.12M(+32.1%) | $599.68M(+4.2%) |
| Sep 2018 | - | $145.40M(+23.5%) | $575.35M(+4.9%) |
| Jun 2018 | - | $117.75M(-18.5%) | $548.27M(+1.0%) |
| Mar 2018 | - | $144.42M(-13.9%) | $542.80M(+5.6%) |
| Dec 2017 | $514.18M(+37.9%) | $167.79M(+41.8%) | $514.18M(-3.5%) |
| Sep 2017 | - | $118.31M(+5.4%) | $532.89M(+1.4%) |
| Jun 2017 | - | $112.27M(-3.0%) | $525.50M(+16.3%) |
| Mar 2017 | - | $115.80M(-37.9%) | $451.70M(+21.2%) |
| Dec 2016 | $372.78M(+31.4%) | $186.50M(+68.1%) | $372.77M(+56.7%) |
| Sep 2016 | - | $110.93M(+188.3%) | $237.84M(+35.1%) |
| Jun 2016 | - | $38.47M(+4.3%) | $176.03M(-31.8%) |
| Mar 2016 | - | $36.87M(-28.5%) | $257.99M(-9.1%) |
| Dec 2015 | $283.70M(+32.5%) | $51.57M(+5.0%) | $283.70M(-10.5%) |
| Sep 2015 | - | $49.12M(-59.2%) | $316.99M(+1.6%) |
| Jun 2015 | - | $120.43M(+92.4%) | $311.94M(+25.5%) |
| Mar 2015 | - | $62.58M(-26.3%) | $248.58M(+16.1%) |
| Dec 2014 | $214.16M(+45.4%) | $84.86M(+92.6%) | $214.16M(+24.8%) |
| Sep 2014 | - | $44.06M(-22.8%) | $171.55M(+13.6%) |
| Jun 2014 | - | $57.08M(+102.7%) | $151.07M(+14.4%) |
| Mar 2014 | - | $28.16M(-33.3%) | $132.09M(-10.3%) |
| Dec 2013 | $147.28M(+44.3%) | $42.25M(+79.1%) | $147.29M(+17.9%) |
| Sep 2013 | - | $23.59M(-38.1%) | $124.91M(+10.6%) |
| Jun 2013 | - | $38.09M(-12.1%) | $112.93M(-7.6%) |
| Mar 2013 | - | $43.36M(+118.2%) | $122.17M(+19.7%) |
| Dec 2012 | $102.05M(+3.0%) | $19.87M(+71.3%) | $102.05M(-10.9%) |
| Sep 2012 | - | $11.60M(-75.5%) | $114.58M(-7.4%) |
| Jun 2012 | - | $47.34M(+103.7%) | $123.69M(+22.3%) |
| Mar 2012 | - | $23.23M(-28.3%) | $101.17M(+2.1%) |
| Dec 2011 | $99.09M(-8.7%) | $32.40M(+56.4%) | $99.09M(+6.4%) |
| Sep 2011 | - | $20.71M(-16.6%) | $93.10M(-7.8%) |
| Jun 2011 | - | $24.82M(+17.4%) | $101.01M(+1.3%) |
| Mar 2011 | - | $21.15M(-20.0%) | $99.69M(-8.1%) |
| Dec 2010 | $108.47M(-10.8%) | $26.42M(-7.7%) | $108.47M(-5.1%) |
| Sep 2010 | - | $28.62M(+21.8%) | $114.31M(+1.6%) |
| Jun 2010 | - | $23.50M(-21.5%) | $112.46M(-6.2%) |
| Mar 2010 | - | $29.93M(-7.2%) | $119.95M(-1.4%) |
| Dec 2009 | $121.60M(+13.4%) | $32.26M(+20.5%) | $121.60M(+2.2%) |
| Sep 2009 | - | $26.77M(-13.6%) | $118.99M(-2.2%) |
| Jun 2009 | - | $30.99M(-1.8%) | $121.68M(+1.1%) |
| Mar 2009 | - | $31.58M(+6.5%) | $120.39M(+12.3%) |
| Dec 2008 | $107.19M(+83.7%) | $29.65M(+0.6%) | $107.19M(+17.8%) |
| Sep 2008 | - | $29.46M(-0.8%) | $90.99M(-9.2%) |
| Jun 2008 | - | $29.70M(+61.6%) | $100.16M(+34.9%) |
| Mar 2008 | - | $18.38M(+36.6%) | $74.27M(+27.3%) |
| Dec 2007 | $58.34M | $13.45M(-65.2%) | $58.34M(+23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2007 | - | $38.63M(+913.1%) | $47.17M(+300.1%) |
| Jun 2007 | - | $3.81M(+55.6%) | $11.79M(-4.6%) |
| Mar 2007 | - | $2.45M(+7.8%) | $12.35M(-16.9%) |
| Dec 2006 | $14.86M(-63.0%) | $2.27M(-30.2%) | $14.86M(-45.4%) |
| Sep 2006 | - | $3.25M(-25.6%) | $27.23M(-13.4%) |
| Jun 2006 | - | $4.38M(-11.8%) | $31.43M(-16.5%) |
| Mar 2006 | - | $4.96M(-66.1%) | $37.65M(-6.2%) |
| Dec 2005 | $40.13M(-5.8%) | $14.64M(+96.3%) | $40.13M(+8.8%) |
| Sep 2005 | - | $7.46M(-29.6%) | $36.88M(-4.2%) |
| Jun 2005 | - | $10.59M(+42.3%) | $38.51M(+2.0%) |
| Mar 2005 | - | $7.44M(-34.6%) | $37.76M(-11.4%) |
| Dec 2004 | $42.62M(-14.7%) | $11.38M(+25.2%) | $42.62M(+4.1%) |
| Sep 2004 | - | $9.09M(-7.6%) | $40.94M(-5.1%) |
| Jun 2004 | - | $9.84M(-20.0%) | $43.14M(-10.7%) |
| Mar 2004 | - | $12.30M(+26.8%) | $48.31M(-3.4%) |
| Dec 2003 | $49.99M(-37.7%) | $9.70M(-14.1%) | $49.99M(-19.6%) |
| Sep 2003 | - | $11.29M(-24.8%) | $62.15M(-12.7%) |
| Jun 2003 | - | $15.02M(+7.4%) | $71.16M(-6.6%) |
| Mar 2003 | - | $13.98M(-36.0%) | $76.20M(-5.0%) |
| Dec 2002 | $80.18M(+50.5%) | $21.86M(+7.7%) | $80.18M(+0.1%) |
| Sep 2002 | - | $20.30M(+1.2%) | $80.06M(+1.3%) |
| Jun 2002 | - | $20.06M(+11.7%) | $79.07M(+18.7%) |
| Mar 2002 | - | $17.96M(-17.4%) | $66.60M(+25.0%) |
| Dec 2001 | $53.27M(+43.0%) | $21.74M(+12.6%) | $53.27M(+35.0%) |
| Sep 2001 | - | $19.30M(+154.3%) | $39.47M(+2.7%) |
| Jun 2001 | - | $7.59M(+63.9%) | $38.44M(+1.6%) |
| Mar 2001 | - | $4.63M(-41.6%) | $37.83M(+1.6%) |
| Dec 2000 | $37.26M(+9.9%) | $7.94M(-56.6%) | $37.26M(-4.0%) |
| Sep 2000 | - | $18.28M(+161.7%) | $38.82M(+24.7%) |
| Jun 2000 | - | $6.99M(+72.3%) | $31.14M(-0.7%) |
| Mar 2000 | - | $4.05M(-57.3%) | $31.35M(-7.5%) |
| Dec 1999 | $33.90M(-13.5%) | $9.50M(-10.4%) | $33.90M(+5.6%) |
| Sep 1999 | - | $10.60M(+47.2%) | $32.10M(-22.5%) |
| Jun 1999 | - | $7.20M(+9.1%) | $41.40M(+3.5%) |
| Mar 1999 | - | $6.60M(-14.3%) | $40.00M(+2.0%) |
| Dec 1998 | $39.20M(+19.9%) | $7.70M(-61.3%) | $39.20M(-4.6%) |
| Sep 1998 | - | $19.90M(+243.1%) | $41.10M(+21.6%) |
| Jun 1998 | - | $5.80M(0.0%) | $33.80M(0.0%) |
| Mar 1998 | - | $5.80M(-39.6%) | $33.80M(+3.7%) |
| Dec 1997 | $32.70M(+44.1%) | $9.60M(-23.8%) | $32.60M(+10.5%) |
| Sep 1997 | - | $12.60M(+117.2%) | $29.50M(+34.1%) |
| Jun 1997 | - | $5.80M(+26.1%) | $22.00M(+5.3%) |
| Mar 1997 | - | $4.60M(-29.2%) | $20.90M(-7.9%) |
| Dec 1996 | $22.70M(+74.6%) | $6.50M(+27.5%) | $22.70M(+15.8%) |
| Sep 1996 | - | $5.10M(+8.5%) | $19.60M(+7.7%) |
| Jun 1996 | - | $4.70M(-26.6%) | $18.20M(+8.3%) |
| Mar 1996 | - | $6.40M(+88.2%) | $16.80M(+29.2%) |
| Dec 1995 | $13.00M(+28.7%) | $3.40M(-8.1%) | $13.00M(+71.1%) |
| Sep 1995 | - | $3.70M(+12.1%) | $7.60M(+7.0%) |
| Jun 1995 | - | $3.30M(+26.9%) | $7.10M(+2.9%) |
| Mar 1995 | - | $2.60M(-230.0%) | $6.90M(0.0%) |
| Dec 1994 | $10.10M(-16.5%) | -$2.00M(-162.5%) | $6.90M(-41.5%) |
| Sep 1994 | - | $3.20M(+3.2%) | $11.80M(-0.8%) |
| Jun 1994 | - | $3.10M(+19.2%) | $11.90M(-0.8%) |
| Mar 1994 | - | $2.60M(-10.3%) | $12.00M(-0.8%) |
| Dec 1993 | $12.10M(+39.1%) | $2.90M(-12.1%) | $12.10M(+23.5%) |
| Sep 1993 | - | $3.30M(+3.1%) | $9.80M(0.0%) |
| Jun 1993 | - | $3.20M(+18.5%) | $9.80M(+10.1%) |
| Mar 1993 | - | $2.70M(+350.0%) | $8.90M(+2.3%) |
| Dec 1992 | $8.70M(+38.1%) | $600.00K(-81.8%) | $8.70M(-2.2%) |
| Sep 1992 | - | $3.30M(+43.5%) | $8.90M(+17.1%) |
| Jun 1992 | - | $2.30M(-8.0%) | $7.60M(+11.8%) |
| Mar 1992 | - | $2.50M(+212.5%) | $6.80M(+17.2%) |
| Dec 1991 | $6.30M(+215.0%) | $800.00K(-60.0%) | $5.80M(+5.5%) |
| Sep 1991 | - | $2.00M(+33.3%) | $5.50M(+37.5%) |
| Jun 1991 | - | $1.50M(0.0%) | $4.00M(+33.3%) |
| Mar 1991 | - | $1.50M(+200.0%) | $3.00M(+50.0%) |
| Dec 1990 | $2.00M | $500.00K(0.0%) | $2.00M(+33.3%) |
| Sep 1990 | - | $500.00K(0.0%) | $1.50M(+50.0%) |
| Jun 1990 | - | $500.00K(0.0%) | $1.00M(+100.0%) |
| Mar 1990 | - | $500.00K | $500.00K |
FAQ
- What is Ionis Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual revenue year-on-year change?
- What is Ionis Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly revenue year-on-year change?
- What is Ionis Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM revenue year-on-year change?
What is Ionis Pharmaceuticals annual revenue?
The current annual revenue of IONS is $705.14M
What is the all time high annual revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual revenue is $1.12B
What is Ionis Pharmaceuticals annual revenue year-on-year change?
Over the past year, IONS annual revenue has changed by -$82.51M (-10.48%)
What is Ionis Pharmaceuticals quarterly revenue?
The current quarterly revenue of IONS is $131.61M
What is the all time high quarterly revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly revenue is $493.68M
What is Ionis Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, IONS quarterly revenue has changed by +$12.12M (+10.14%)
What is Ionis Pharmaceuticals TTM revenue?
The current TTM revenue of IONS is $717.25M
What is the all time high TTM revenue for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM revenue is $1.12B
What is Ionis Pharmaceuticals TTM revenue year-on-year change?
Over the past year, IONS TTM revenue has changed by -$59.37M (-7.64%)